HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination treatment with whole body vibration and a kidney-tonifying herbal Fufang prevent osteoporosis in ovariectomized rats.

AbstractOBJECTIVE:
To assess the ability of whole body vibration (WBV) with the kidney-tonifying herbal Fufang (Bushen Zhuanggu Granules, BZG) to prevent osteoporosis in ovariectomized rats.
METHODS:
Fifty 6-month-old female Sprague Dawley rats were divided into five groups: sham-operated (SHAM), ovariectomized (OVX), OVX with WBV (OVX + WBV), OVX with BZG (OVX + BZG), OVX with both WBV and BZG (OVX + WBV + BZG). The SHAM group received normal saline. After 12 weeks of treatment, the rats were killed, their serum concentrations of osteopontin (OPN), receptor activator of nuclear factor kappa-B ligand RANKL and bone turnover markers assayed and bone mineral density (BMD), histomorphometry and bone strength evaluated.
RESULTS:
Concentrations of OPN were significantly lower in the SHAM, OVX + WBV and OVX + WBV + BZG groups at 12 weeks, whereas concentrations of RANKL had decreased significantly in the SHAM, OVX + WBV, OVX + BZG and OVX + WBV + BZG groups. In the OVX + WBV, OVX + BZG and OVX + WBV + BZG groups the amount of bone turnover had been significantly antagonized. Compared with OVX group, BMD, % trabecular area (Tb.Ar), number of trabeculae (Tb.N) and assessed biomechanical variables were higher in OVX+WBV group, whereas and BMD, %Tb.Ar, Tb.N, maximal load and yield load were higher in the OVX + BZG group. All tested indices were significantly lower in the OVX + WBV and OVX + BZG groups than in the OVX + WBV + BZG group.
CONCLUSION:
Either WBV or BZG alone prevents OVX-induced bone loss. However, BZG enhances the effect of WBV by further enhancing BMD, bone architecture and strength.
AuthorsQiu-shi Wei, Hai-bin Wang, Jun-ling Wang, Bin Fang, Guang-quan Zhou, Xin Tan, Wei He, Wei-min Deng
JournalOrthopaedic surgery (Orthop Surg) Vol. 7 Issue 1 Pg. 57-65 (Feb 2015) ISSN: 1757-7861 [Electronic] Australia
PMID25708037 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 Chinese Orthopaedic Association and Wiley Publishing Asia Pty Ltd.
Chemical References
  • Bone Density Conservation Agents
  • Drugs, Chinese Herbal
  • bushen zhuanggu
Topics
  • Animals
  • Bone Density Conservation Agents (therapeutic use)
  • Combined Modality Therapy
  • Drugs, Chinese Herbal (therapeutic use)
  • Female
  • Osteoporosis (etiology, prevention & control)
  • Ovariectomy
  • Postoperative Complications (prevention & control)
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Treatment Outcome
  • Vibration (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: